These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 929778)

  • 1. The evaluation of some biochemical parameters in pyridoxine-treated calcium oxalate renal stone formers.
    Revúsová V; Gratzlová J; Zvara V; Kridl J; Suchánek B; Breza J
    Urol Int; 1977; 32(4):348-52. PubMed ID: 929778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.
    Rattan V; Sidhu H; Vaidyanathan S; Thind SK; Nath R
    Urol Res; 1994; 22(3):161-5. PubMed ID: 7992461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution to therapeutic decisions of ratios, absolute values and other measures of calcium, magnesium, urate or oxalate balance in stone formers.
    Drach GW
    J Urol; 1976 Sep; 116(3):338-40. PubMed ID: 957503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine.
    Scholz D; Schwille PO; Ulbrich D; Bausch WM; Sigel A
    Urol Res; 1979 Sep; 7(3):161-70. PubMed ID: 505679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention.
    Pucci ND; Marchini GS; Mazzucchi E; Reis ST; Srougi M; Evazian D; Nahas WC
    Int Braz J Urol; 2018; 44(4):758-764. PubMed ID: 29617079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
    Nguyen QV; Kälin A; Drouve U; Casez JP; Jaeger P
    Kidney Int; 2001 Jun; 59(6):2273-81. PubMed ID: 11380831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative element investigations in urine, serum, kidney and muscle tissue of calcium oxalate stone patients.
    Matouschek E; Huber R; Schneider J; Vogg H
    Eur Urol; 1978; 4(3):206-11. PubMed ID: 658076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
    Kaelin A; Casez JP; Jaeger P
    Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of potential renal acid load of foods on calcium metabolism of renal calcium stone formers.
    Trinchieri A; Zanetti G; Currò A; Lizzano R
    Eur Urol; 2001 Jan; 39 Suppl 2():33-6; discussion 36-7. PubMed ID: 11223695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.